CClinicalTrials.gg
CompletedNCT07570706LP-NOSEUpdated May 6, 2026

Mucosal and Nasal Involvement and Their Correlation With Smell and Taste Functions in Lichen Planus Patients

An observational study in Lichen Planus, sponsored by Istanbul Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-06.

Sponsored by Istanbul Training and Research Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
88
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study investigates smell and taste function in patients diagnosed with lichen planus, a chronic inflammatory condition affecting the skin and mucous membranes.

Adults aged 18-65 with lichen planus participated in taste and smell tests. Oral and nasal examinations were performed to check for mucosal involvement, and nasal endoscopy was used to further evaluate nasal involvement.

A healthy control group of similar age also underwent taste and smell tests to compare results with the lichen planus patients.

The study aims to better understand how lichen planus affects smell and taste, which may help improve patient care. Participation is voluntary, and all information collected will be kept confidential.

Read the detailed description

The study aims to evaluate the impact of lichen planus on olfactory and gustatory functions in adults aged 18-65. Participants with lichen planus underwent taste and smell testing, oral and nasal mucosal examinations, and nasal endoscopy to detect potential mucosal involvement. A matched healthy control group also completed taste and smell tests to provide comparative data. This design allows the assessment of whether mucosal involvement in lichen planus correlates with changes in taste and smell, which may contribute to better clinical understanding and management of the disease.

02

Conditions studied

  • Lichen Planus

Browse trials for

Keywords

  • Lichen Planus
  • Taste Function
  • Smell Function
  • Olfactory Testing
  • Gustatory Testing
  • Nasal Endoscopy
  • Oral Mucosa
  • Nasal Mucosa
  • Mucosal Involvement
  • Healthy Controls
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study includes adults aged 18-65 years with a clinical diagnosis of lichen planus, as well as healthy volunteers without lichen planus. Participants were assessed for smell and taste function, and the patient group also underwent oral and nasal mucosal examinations, including nasal endoscopy. Both male and female participants were included.

Inclusion criteria

Age 18-65 years Clinically diagnosed with lichen planus (patient group) Healthy individuals without lichen planus (control group) Willing and able to provide informed consent

Exclusion criteria

Exclusion Criteria:

Nasal septum deviation Nasal polyposis, congenital olfactory dysfunction, chronic rhinosinusitis, or allergic rhinitis History of head trauma History of nasal or paranasal surgery Psychiatric or neurological disorders (e.g., Parkinson's disease, Alzheimer's disease) Persistent loss of smell following COVID-19 infection Pregnancy or breastfeeding

04

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
88 participants (actual)
Patient registry
No

Groups and cohorts

  • Group 1- Lichen Planus Patients

    Participants undergo taste and smell testing, oral and nasal examinations, and nasal endoscopy to assess mucosal involvement.

    Other: Grup 1 - Lichen Planus Patients Intervention Name: Taste and Smell Testing, Oral and Nasal Examination, Nasal Endoscopy Intervention Description: Participants undergo taste and smell testing to assess

  • Group 2 - Healthy Controls

    Participants undergo taste and smell testing to provide comparative data with the lichen planus group.

    Other: Grup 1 - Lichen Planus Patients Intervention Name: Taste and Smell Testing, Oral and Nasal Examination, Nasal Endoscopy Intervention Description: Participants undergo taste and smell testing to assess

Interventions

  • OtherGrup 1 - Lichen Planus Patients Intervention Name: Taste and Smell Testing, Oral and Nasal Examination, Nasal Endoscopy Intervention Description: Participants undergo taste and smell testing to assess

    Group 1 - Lichen Planus Patients: Participants undergo taste and smell testing to assess sensory function, oral and nasal examinations to evaluate mucosal involvement, and nasal endoscopy for detailed nasal assessment. Group 2 - Healthy Controls: Participants undergo taste and smell testing to provide comparative data for the lichen planus group.

05

What researchers measure

Primary outcomes

  1. Smell and Taste Function

    Participants underwent standardized smell (olfactory) and taste (gustatory) tests to assess sensory function. Tests were performed on both lichen planus patients and healthy controls to compare results and evaluate the impact of mucosal involvement on smell and taste function. Time Frame: Single visit assessment

    Time frame: Day 1

  2. Smell and taste function in patients with lichen planus

    Participants underwent standardized smell (olfactory) and taste (gustatory) tests to assess sensory function. Tests were performed on both lichen planus patients and healthy controls to compare results and evaluate the impact of mucosal involvement on smell and taste function.

    Time frame: Day 1

06

Study locations

1 site
  • S.B.U. Istanbul Training and Research Hospital
    Istanbul, Istanbul 34098, Turkey (Türkiye)
07

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared due to privacy and confidentiality considerations for study participants.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07570706
Lead sponsor
Istanbul Training and Research Hospital
Responsible party
Yasemin Bolat Eren (Principal investigator, Istanbul Training and Research Hospital) — Principal investigator
First posted
May 6, 2026
Start date
Jan 1, 2026
Primary completion
Mar 20, 2026
Completion
Apr 2, 2026
Last update
May 6, 2026

Study contacts

Yasemin Bolat Eren, MD
principal investigator · S.B.U. Istanbul Eğitim ve Araştırma Hastanesi, Dermatology Department

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion